MyChesCo on MSN11d
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational IncomeOptinose (NASDAQ: OPTN) has announced its financial results for the year and quarter ending December 31, 2024, spotlighting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback